Lymphoma - Clinical Research
1 – 10 of 23
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
- Randomized, phase 3 trial of inotuzumab ozogamicin plus rituximab versus chemotherapy plus rituximab for relapsed/refractory aggressive B-cell non-Hodgkin lymphoma
- Targeting of B-cell receptor signalling in B-cell malignancies
- Estrogen receptor β1 in diffuse large B-cell lymphoma growth and as a prognostic biomarker
- Frequency and clinical implications of SOX11 expression in Burkitt lymphoma
- Impact of comorbidity on survival in peripheral T-cell lymphomas : A Swedish Lymphoma Registry study
- The addition of etoposide to CHOP is associated with improved outcome in ALK+ adult anaplastic large cell lymphoma : A Nordic Lymphoma Group study
- 2016
- Lenalidomide-bendamustine-rituximab in untreated mantle cell lymphoma > 65 years, the Nordic Lymphoma Group phase I+II trial NLG-MCL4
- Högintensiv cytostatikaterapi ökade överlevnad vid burkitts lymfom
- Distinct global binding patterns of the Wilms' tumor gene 1 (WT1) -KTS and +KTS isoforms in leukemic cells
- Season of diagnosis is associated with overall survival in patients with diffuse large B-cell lymphoma but not with Hodgkin's lymphoma - A population-based Swedish Lymphoma Register study.